Result page for
Withdrawn ID 1415:
Nalmefene

General information:
Withdrawal information:
| Withdrawn due to drug safety reasons: | No |
| First approved: |
1995 |
Side-effects:
| Total reported cases (submitted by medical professionals)
with Nalmefene as primary suspect: |
2 |
Reported final outcomes:
Reported side-effects:
| Side-effect |
Case number |
| Intentional overdose | 2 |
| Agitation | 1 |
| ASTHENIA | 1 |
| DIARRHOEA | 1 |
| EPIGASTRIC DISCOMFORT | 1 |
| FATIGUE | 1 |
| LOOSE STOOLS | 1 |
| NAUSEA | 1 |
| Suicide attempt | 1 |
| VOMITING | 1 |
Filtered ChEMBL targets:
| Target UniProtKB ID |
Activity in nm |
Target Name |
Target gene |
| P35372 |
0.24 |
Mu-type opioid receptor |
OPRM_HUMAN |
| P41143 |
0.912 |
Delta-type opioid receptor |
OPRD_HUMAN |
| P41145 |
0.083 |
Kappa-type opioid receptor |
OPRK_HUMAN |
Toxicity information:
|
Toxicity class: |
4 |
| Toxicity type: |
N/A |
| LD50: |
402 mg/kg |
External links: